Analysis evaluates biomarker dynamics in patients with urothelial cancer receiving ipilimumab and nivolumab, revealing treatment outcomes.
Consort diagram of available samples per analysis for each arm at baseline and on-treatment. One patient in arm 2A and 3 patients in arm 2B did not undergo cystectomy.
No takes yet. Share an insight, caveat, or question.
Stockem et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: